New adjuvant therapies for esophageal cancer

Adv Surg. 2001:35:271-95.

Authors

S Law¹, J Wong

Affiliation

¹ University of Hong Kong Medical Centre, Division of Esophageal Surgery, Department of Surgery, Queen Mary Hospital, Hong Kong, China.

PMID: 11579815

No abstract available

Publication types

Review

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Camptothecin / analogs & derivatives*
Camptothecin / therapeutic use
Chemotherapy, Adjuvant
Cisplatin / therapeutic use
Digestive System Surgical Procedures
Docetaxel
Esophageal Neoplasms / drug therapy*
Esophageal Neoplasms / radiotherapy*
Esophageal Neoplasms / surgery
Fluorouracil / therapeutic use
Humans
Irinotecan
Neoadjuvant Therapy*
Paclitaxel / analogs & derivatives*
Paclitaxel / therapeutic use
Radiotherapy, Adjuvant
Taxoids*

Substances

Taxoids
Docetaxel
Irinotecan
Paclitaxel
Cisplatin
Fluorouracil
Camptothecin